MYFORTIC 180mg (Mycophenolate Mofetil)

MYFORTIC 180mg (Mycophenolate Mofetil) Product Description

MYFORTIC 180mg, containing Mycophenolate Mofetil, is an immunosuppressive medication primarily used to prevent organ rejection in transplant patients. It works by inhibiting the proliferation of lymphocytes, thereby reducing the immune response against transplanted organs.

Indications

This medication is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal transplants. It may also be used in combination with other immunosuppressants for enhanced efficacy.

Dosage and Administration

The recommended dosage of MYFORTIC should be determined by a healthcare provider based on the patient's condition and response to treatment. It is typically taken orally, with or without food, to maintain consistent drug levels in the bloodstream.

Possible Side Effects

Common side effects may include gastrointestinal disturbances, such as diarrhea, nausea, and abdominal pain. Serious side effects can occur, including increased risk of infections and malignancies. Patients should be monitored regularly for any adverse reactions.

Precautions

Prior to using MYFORTIC, patients should inform their healthcare provider of any pre-existing conditions, allergies, or concurrent medications. Regular blood tests may be required to monitor kidney function and immune system status.

Drug Interactions

MYFORTIC may interact with other medications, potentially altering their effects. It is essential to inform healthcare providers of all medications being taken, including over-the-counter drugs and supplements.

Storage Instructions

Store MYFORTIC at room temperature, away from moisture and heat. Keep out of reach of children and pets.

Conclusion

MYFORTIC 180mg is a vital medication for patients undergoing organ transplants, helping to ensure the success of the procedure while minimizing the risk of rejection. Always consult with a healthcare professional for personalized medical advice.